Advisors Asset Management, Inc. Ligand Pharmaceuticals Inc Transaction History
Advisors Asset Management, Inc.
- $5.1 Billion
- Q1 2025
A detailed history of Advisors Asset Management, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 2,841 shares of LGND stock, worth $295,975. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,841
Previous 2,252
26.15%
Holding current value
$295,975
Previous $241,000
23.65%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$299 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$214 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$107 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$94.4 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$77.6 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.76B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...